If you want to beat a fearsome enemy, you must first learn to think like them. If you do, you can predict their next move – and block it. This advice may work on the battlefield. But scientists also think it will work in humankind’s battle against one of the most dangerous bacteria our bodies can face: Clostridium difficile.
Depression can strike anyone, taking a toll on mental and physical health, friendships, work and studies. But figuring out who’s at risk for it is still a murky task. A new U-M study suggests that standard ways of looking for depression risk may not work as well among blacks as they do among whites.
When you buy a cup of coffee, a load of groceries, an airline ticket or a tank of gas these days, you probably pull out a customer loyalty card without even thinking about it. Could a health system loyalty card be next?
Paul Lee’s JAMA editorial highlights the strengths of the U.S. Preventive Services Task Force’s methods while acknowledging some difficulties in carrying out the recommendations of the task force and the possible implications of ongoing change in the care delivery system.
Once you’ve made it through lung cancer treatment, you want to make sure you catch it early if it comes back again. But a new study suggests that one approach to watching for a cancer’s return is being inappropriately used at many hospitals. And it isn’t helping patients survive longer.
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective mechanism against itself — short-circuiting tumor cell metabolism and killing tumor cells.
By looking at data from 10 Michigan hospitals participating in an unprecedented collaborative quality-improvement effort, researchers have shown how much variation exists when it comes to the use of intravenous devices called peripherally inserted central catheters, or PICCs.
U-M has established the Renal Pre-Competitive Consortium (RPC2), with several pharmaceutical companies, including AstraZeneca and Eli Lilly and Company. The consortium will develop and use large-scale data exploration to identify new treatment targets for chronic kidney disease.
They may dream of becoming doctors, and helping people like themselves. But for young people with disabilities, that dream may die when they check the admissions standards of most medical schools, according to a new U-M-led study.
One of the most common cancer-causing genes has continuously stymied researchers’ efforts to develop treatments against it. Now, researchers have dug deeper and exposed a key interaction that may contribute to why mutations in KRAS lead to cancer.
When it comes to prescription painkillers, the difference between controlling pain and dying from an overdose may come down to how strong a prescription the doctor wrote, according to a new study in veterans.
Marijuana use over time is associated with remembering fewer words from a list, but it did not appear to affect other areas of cognitive function in a study of men and women followed up over 25 years, a new study finds.
You wouldn’t think that two Turkish children, some yeast and a bunch of Hungarian fruit flies could teach scientists much. But in fact, that unlikely combination has just helped an international team make a key discovery about how the brain’s “garbage disposal” process works — and how little needs to go wrong in order for it to break down.
The University of Michigan Center for Integrative Research in Critical Care (MCIRCC) has partnered with the U.S. Department of Defense (DoD) to find new research aiming to impact the way severe traumatic brain injury is diagnosed and treated.